Predicting Clinical Efficacy of Immunotherapy Using Pre-treatment andContinuousMonitoring of PD-L1 TPS/CPS on CTCs, and Immunity Exhaustion Scores

Clinical trial NCT07396259 · RECRUITING

Trial details

NCT number: NCT07396259
Sponsor: Chang Gung Memorial Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Circulating Tumor Cells (CTCs)Immunotherapy PD-L1 Expression Liquidbiopsies

Start date: 2025-02-25
Primary completion: 2030-12-31
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.